Table 2.

Demographics and clinical characteristics of patients with C. albicans and non-albicans candidaemia

Characteristics	C. albicans n = 64 (35.6%)	Non-albicans n = 116 (64.4%)	P Value
Age	61.3 ± 15.1	62.2 ± 16.5	0.726
Male sex	41 (64.1%)	81 (69.8%)	0.428
Underlying diseases
Haematological malignancy	3 (4.7%)	4 (3.4%)	0.993
Solid tumours	28 (43.8%)	52 (44.8%)	0.889
Diabetes mellitus	16 (25%)	25 (21.6%)	0.597
Predisposing factors
Dialysis	2 (3.1%)	6 (5.2%)	0.795
Current and former smokers	14 (21.9%)	40 (34.5%)	0.077
ICU stay	19 (29.7%)	37 (31.9%)	0.759
Surgical patients	45 (70.3%)	93 (80.2%)	0.134
Recent abdominal surgery	35 (54.7%)	73 (62.9%)	0.280
Recent cancer surgery	25 (39.1%)	46 (39.7%)	0.938
Prior antibiotics exposure	60 (93.8%)	103 (88.8%)	0.276
Prior antifungal exposure	8 (12.5%)	18 (15.5%)	0.581
TPN	50 (78.1%)	102 (87.9%)	0.082
Presence of CVC	28 (43.8%)	40 (34.5%)	0.220
Mechanical ventilation	3 (4.7%)	9 (7.8%)	0.632
Presence of urethral catheter	47 (73.4%)	68 (58.6%)	0.048
Presence of gastric tube	42 (65.6%)	80 (69%)	0.646
Laboratory findings
Renal failure	13 (20.3%)	25 (21.6%)	0.845
Anaemia	49 (76.6%)	99 (85.3%)	0.140
Hypoalbuminaemia	26 (40.6%)	44 (37.9%)	0.723
Hyponatraemia	18 (28.1%)	50 (43.1%)	0.047
Leukopaenia	9 (14.1%)	16 (13.8%)	0.960
Thrombocytopaenia	10 (15.6%)	18 (15.5%)	0.985
Fluconazole susceptibility	57 (89.1%)	72 (62.1%)	<0.001
Outcome
Crude 30-day mortality	23 (35.9%)	23 (19.8%)	0.018
LOS (days)	28 (21–38.3)	30 (20–48)	0.469

ICU, intensive care unit; TPN, total parenteral nutrition; CVC, central venous catheter; LOS, length of hospital stay.